drug protocol number

D589SC00003

drug sponsor

AstraZeneca

drug study

Budesonide / Formoterol / Budesonide / Terbutaline

drug trial site

Armed Forces Hospital (Dhahran), King Fahad Specialist Hospital (Dammam), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad University Hospital (Al-Khobar), King Faisal Specialist Hospital and Research Center (Jeddah)

drug status

Ongoing

drug phase